// App-Quantinova.ai

1226 : Highly specific ATR inhibitors as a therapeutic approach for a broad spectrum of cancers

Researchers

Presenter

  • Laura R. Butler

Principal Investigators

  • Ryan L. Ragland

  • Hank J. Breslin

  • Tina Gill

  • Erin George

  • Fiona Simpkins

  • Eric J. Brown

  • Oren Gilad

Medical Centers

  • Atrin Pharmaceuticals, Doylestown, PA

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ataxia telangiectasia

  • Solid malignancies

Biomarkers

  • Ataxia Telangiectasia And Rad3-Related Protein

  • Checkpoint kinase 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved